Cassava laying off one-third of staff to curb expenses

by
Contributor since / Followers

1 day ago

Cassava Sciences (NASDAQ:SAVA) is laying off 33% of its workforce — 10 employees — as it attempts to conserve cash while awaiting additional phase 3 results for its Alzheimer’s disease asset simufilam.
As of Dec. 31, 2024, the company had $128.6M in cash and

Tags: SAVA